Get the most from your devices with FibroScan Gateway
Seamless integration with electronic health records
FibroScan Gateway connects FibroScan devices and HL7 protocol compliant electronic health records (EHR) applications.
Provider’s orders placed in the EHR appear directly on the FibroScan device based on their scheduled date. The operator simply taps the patient’s name on the screen and begins the exam.
After the exam, FibroScan Gateway automatically transmits the discrete numeric exam results and the PDF report to your EHR for easy retrieval, reviewing and reporting. No manual action to export or store results is required.
Improve workflow efficiency
EHR orders appear directly on FibroScan devices; no manual data entry, printing, scanning, shredding or USB devices. Automated order reconciliation and secure transfer of results.
F&B:
- Reduce exam time by reducing data entry
- Eliminate input errors
- Directly uploads from FibroScan to EHR
Providers can access the PDF and the exam results directly within the EHR
Additional provider benefits
With FibroScan Gateway, providers can access exam results in near real-time, directly from the patient record in the EHR. FibroScan Gateway significantly reduces provider documentation time by providing the numeric results (with units), reference ranges, abnormal flags and guideline comments, that can be pulled directly into a note or referral letter. Additionally, FibroScan Gateway provides interfaced results that trigger charges automatically, avoiding manual charge entries and time chasing lost charges.
Improved patient engagement
Numeric results can be graphed to show patient values over time, used for monitoring population health & future scoring. Examination results sent with FibroScan® Gateway, can also be added to EHR flowsheets to view with AST results.
Indications
The FibroScan Family of Products (Models: 502 Touch, 530 Compact, and 430 Mini+) is intended to provide 50Hz shear wave speed measurements and estimates of tissue stiffness as well as 3.5 MHz ultrasound coefficient of attenuation (CAP: Controlled Attenuation Parameter) in internal structures of the body.
FibroScan Family of Products (Models: 502 Touch, 530 Compact, and 430 Mini+) is indicated for noninvasive measurement in the liver of 50Hz shear wave speed and estimates of stiffness as well as 3.5MHz ultrasound coefficient of attenuation (CAP: Controlled Attenuation Parameter).
The shear wave speed and stiffness, and CAP may be sued as an aid to diagnosis and monitoring of adult patients with liver disease, as part of an overall assessment of the liver.
Shear wave speed and stiffness may be used as an aid to clinical management of pediatric patients with liver disease.
Current media
Diabetes Wake-Up Call: Liver Screening Tools Help Battle Obesity-Related Diseases
Join us in raising awareness about American Diabetes Association Diabetes Alert Day®, March 23, 2021 Every fourth Tuesday in March, Diabetes Alert Day represents a one-day “wake-up call” that brings…
Read More
Fatty Liver Disease Impacts Minority Populations: April 2021 is National Minority Health Month
Join Echosens in helping raise awareness about the importance of early detection of liver disease. (more…)
Read More
COVID-19 Impact: Higher Risks of Severity Among Obese and Chronic Liver Disease Patients
The COVID-19 pandemic has emerged as a complicated and pernicious disease. Recently, the Centers for Disease Control and Prevention (CDC) warns that adults of any age with certain underlying medical conditions are…
Read More
Contact a representative
In North America there are over 1200+ FibroScan systems in operation & we’re growing!
